Comprehensive Biomarker Center named agilent technologies certified service provider for custom microrna array services

HEIDELBERG, September 30, 2015 – Comprehensive Biomarker Center GmbH today announced that it has been named an Agilent Technologies Certified Service Provider for microRNA profiling. As a new Agilent provider of custom microRNA array services, CBC will assure reliable and continuously high-quality methods, technologies and data analysis services.

Heidelberg-based CBC has recently been accredited according to ISO DIN/EN 17025:2005 in the extraction of total RNA from body fluids and the analysis of microRNA and mRNA using the Agilent microarray platform.

“We are very pleased to have the CBC as a provider in our CSP program,” says Frédéric Laget, Vice President Global Commercial Organization, Diagnostics & Genomics at Agilent. “CBC’s highly qualified and experienced team is known for its unique expertise in circulating biomarkers from body fluids. Having CBC as a new provider for custom microRNA array solutions and a leading expert in the field of circulating microRNA biomarkers promises to deliver real value to the genomics community.”

Jochen Kohlhaas, chief executive officer at CBC GmbH, comments:“Having worked for several years with Agilent’s microarrays, we value the robust and reliable technology platform. We’re committed to providing high-quality and effective solutions to our customers. The certification, in addition to our ISO DIN/EN 17025:2005 accreditation, will assure our customers high-quality results.”

Agilent offers its CSP program to selected service provider laboratories that will leverage Agilent's technologies in providing the highest-quality analysis services to their customers.

The CBC offers a certification on Agilent’s microRNA microarray platform and is an expert on microRNA profiling from circulating body fluids. The certificate ensures that customers receive consistent data quality, reproducibility, and reliability for their discovery research.

About CBC:

Located in the Biotechnology Park in Heidelberg, Germany, CBC discovers, analyzes and validates microRNA biomarkers from body fluids.

CBC has built a robust fine-tuned discovery engine to generate validated biofluid-markers and IP for IVD, companion diagnostics and drug discovery. At the core of CBC is a proven, quality-controlled Biomarker engine combined with an unrivalled high-quality microRNA whole blood database. CBC is an „Agilent Certified Services Provider” and accredited according to DIN EN ISO/IEC 17025:2005.

For further information please contact:

Comprehensive Biomarker Center GmbH

Im Neuenheimer Feld 583 69120 Heidelberg
Tel.: +49 (0)6221 91433-10 Fax: +49 (0)6221 91433-12